0

BEPREVE از شرکت BAUSCH AND LOMB INC

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

BEPREVE از شرکت BAUSCH AND LOMB INC

New Drug Application (NDA): 022288

Company: BAUSCH AND LOMB INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BEPREVE BEPOTASTINE BESILATE 1.5% SOLUTION/DROPS;OPHTHALMIC Prescription

AT

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/08/2009 ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022288lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022288s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022288s000TOC.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022288s000_SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/09/2018 SUPPL-8 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022288Orig1s008ltr.pdf

02/05/2016 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

06/28/2012 SUPPL-3 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022288s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022288s003ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
02/09/2018 SUPPL-8

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf
06/28/2012 SUPPL-3

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022288s003lbl.pdf
09/08/2009 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022288lbl.pdf

BEPREVE

SOLUTION/DROPS;OPHTHALMIC; 1.5%

TE Code = AT

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BEPOTASTINE BESILATE BEPOTASTINE BESILATE 1.5% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 206066 APOTEX
BEPOTASTINE BESILATE BEPOTASTINE BESILATE 1.5% SOLUTION/DROPS;OPHTHALMIC Prescription No AT 206220 MYLAN
BEPREVE BEPOTASTINE BESILATE 1.5% SOLUTION/DROPS;OPHTHALMIC Prescription Yes AT 022288 BAUSCH AND LOMB INC
حتما بخوانید : A-METHAPRED از شرکت ABBOTT
برچسب‌ها:

نظرات کاربران